Company News
J. Michael Pearson returns as CEO of Valeant following illness
J. Michael Pearson returns as CEO of Valeant following illness
Robert A. Ingram appointed Chairman of the Board as the roles of Chairman and CEO are separated
French biopharmaceutical firm Pharnext hires two
French biopharmaceutical firm Pharnext hires two
Niall Murphy as Chief Scientific Officer and Pierre Schwich as Chief Financial Officer
Werner Baumann to succeed Marijn Dekkers as Chairman of Bayer's Board of Management
Werner Baumann to succeed Marijn Dekkers as Chairman of Bayer's Board of Management
He will take up the role on 1 May 2016
Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations
Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations
John Yee takes the newly created position at the US biopharmaceutical firm
Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association
Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association
She will hold this position for one year
Torsten Derr to head Lanxess subsidiary Saltigo
Torsten Derr to head Lanxess subsidiary Saltigo
Takes over from Wolfgang Schmidt, who is retiring, on 1 April 2016
Patheon appoints Global Business Controller
Patheon appoints Global Business Controller
Andrew Long will build the firm's financial planning and performance management tools and processes
Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry
Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry
He takes up the position on 1 March and Acting CEO Alison Clough will step down
Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance
Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance
Wood holds more than 20 years of regulatory affairs experience focusing on drugs for diseases with high unmet need
Sygnature Discovery makes two key appointments as expansion continues
Sygnature Discovery makes two key appointments as expansion continues
Also expands its team of scientists by adding six people to the team
Recipharm names 2015 International Environmental Award winner
Recipharm names 2015 International Environmental Award winner
Jerker Fick takes the award for his research into the effect pharmaceuticals have on the environment
Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer
Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer
Cao is a top researcher at the University of Southern Florida in Tampa
Avita makes three key board appointments
Avita makes three key board appointments
Three are based in the US and three in Australia
Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee
Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee
Former CEO of the Clinical Products Division at Siemens Healthcare joins the firm on 1 April
Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics
Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics
Brings operating expertise to development-stage company focused on developing therapies for diseases caused by poor blood flow
Astellas names James Robinson as President, Americas Operations
Astellas names James Robinson as President, Americas Operations
He takes up the role on 1 April, succeeding Masao Yoshida, who retires in June
Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development
Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development
Also joins the Executive Committee at the French drugmaker
New VP of Development and Analytical Services at Catalent
New VP of Development and Analytical Services at Catalent
Sally Langa joins the US drug delivery technology specialist
David Budd to join Epistem as Chief Executive
David Budd to join Epistem as Chief Executive
He will start his new role by the middle of April
CytRx appoints Olivia Ware as Chief Commercial Officer
CytRx appoints Olivia Ware as Chief Commercial Officer
Los Angeles-based firm specialises in oncology and is preparing for the results of a pivotal Phase III trial
Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals
Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals
He previously held managerial and business development roles at Teva Pharmaceuticals and Dexcel Pharma
Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs
Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs
He joins the firm with more than 15 years of vaccine research and development experience and leadership roles
AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business
AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business
Dawn Von Rohr joins AMRI from Mallinckrodt Pharmaceuticals where she was VP and General Manager, Global APIs
Paolo Paoletti joins PsiOxus Therapeutics at Chairman
Paolo Paoletti joins PsiOxus Therapeutics at Chairman
Former President of GSK Oncology adds depth of knowledge of cancer R&D
Werner Baumann to succeed Marijn Dekkers as Chairman of Bayer's Board of Management
Werner Baumann to succeed Marijn Dekkers as Chairman of Bayer's Board of Management
He will take up the role on 1 May 2016
Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations
Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations
John Yee takes the newly created position at the US biopharmaceutical firm
Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association
Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association
She will hold this position for one year
Torsten Derr to head Lanxess subsidiary Saltigo
Torsten Derr to head Lanxess subsidiary Saltigo
Takes over from Wolfgang Schmidt, who is retiring, on 1 April 2016
Patheon appoints Global Business Controller
Patheon appoints Global Business Controller
Andrew Long will build the firm's financial planning and performance management tools and processes
Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry
Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry
He takes up the position on 1 March and Acting CEO Alison Clough will step down
Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance
Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance
Wood holds more than 20 years of regulatory affairs experience focusing on drugs for diseases with high unmet need
Sygnature Discovery makes two key appointments as expansion continues
Sygnature Discovery makes two key appointments as expansion continues
Also expands its team of scientists by adding six people to the team
Recipharm names 2015 International Environmental Award winner
Recipharm names 2015 International Environmental Award winner
Jerker Fick takes the award for his research into the effect pharmaceuticals have on the environment
Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer
Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer
Cao is a top researcher at the University of Southern Florida in Tampa
Avita makes three key board appointments
Avita makes three key board appointments
Three are based in the US and three in Australia
Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee
Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee
Former CEO of the Clinical Products Division at Siemens Healthcare joins the firm on 1 April
Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics
Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics
Brings operating expertise to development-stage company focused on developing therapies for diseases caused by poor blood flow
Astellas names James Robinson as President, Americas Operations
Astellas names James Robinson as President, Americas Operations
He takes up the role on 1 April, succeeding Masao Yoshida, who retires in June
Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development
Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development
Also joins the Executive Committee at the French drugmaker
New VP of Development and Analytical Services at Catalent
New VP of Development and Analytical Services at Catalent
Sally Langa joins the US drug delivery technology specialist
David Budd to join Epistem as Chief Executive
David Budd to join Epistem as Chief Executive
He will start his new role by the middle of April
CytRx appoints Olivia Ware as Chief Commercial Officer
CytRx appoints Olivia Ware as Chief Commercial Officer
Los Angeles-based firm specialises in oncology and is preparing for the results of a pivotal Phase III trial
Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals
Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals
He previously held managerial and business development roles at Teva Pharmaceuticals and Dexcel Pharma
Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs
Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs
He joins the firm with more than 15 years of vaccine research and development experience and leadership roles
AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business
AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business
Dawn Von Rohr joins AMRI from Mallinckrodt Pharmaceuticals where she was VP and General Manager, Global APIs
Paolo Paoletti joins PsiOxus Therapeutics at Chairman
Paolo Paoletti joins PsiOxus Therapeutics at Chairman
Former President of GSK Oncology adds depth of knowledge of cancer R&D